James J. Sciubba, D.M.D., PhD

Dr. Sciubba received his dental undergraduate education at Fairleigh Dickinson University, a Ph.D. in Pathology from the University of Illinois, followed by a fellowship in Oral & Maxillofacial Pathology at the ADA. He has served as a full Professor in the Departments of Otolaryngology-Head and Neck Surgery, Pathology and Dermatology at The Johns Hopkins School of Medicine and at the SUNY Stony Brook, School of Dental Medicine. Dr. Sciubba was the Director if Dental & Oral Medicine at The Johns Hopkins Hospital as well during his tenure at Johns Hopkins. Prior to moving to Johns Hopkins Dr. Sciubba served as Emeritus Chair of Dental Medicine at The Long Island Jewish Medical Center and was accorded Emeritus Professor recognition at Stony Brook University School of Dental Medicine in 1999.

He has over 40 years of experience with oral and head and neck cancer patients and those with oral diseases and conditions as a clinician and pathologist and has published extensively in the areas of oral cancer, oral mucosa! and salivary gland diseases, jawbone pathology and dental education. He is currently in part time private practice in Oral Medicine and Oral Pathology and is a team member and active consultant at The Milton J. Dance Head and Neck Cancer Center located at The Greater Baltimore Medical Center, where an active program exists in the diagnosis, comprehensive management, and rehabilitation of oral and head and neck cancer patients.

Dr. Sciubba has extensive experience in the diagnosis and management of a wide scope of oral, jawbone and salivary diseases. He remains active as an editor, associate editor and reviewer of several journals including Oral Oncology, where he now a senior advisor for editorial policy. He remains or was active with The Compendium of Continuing Dental Education, The Journal of Dental Research I Critical Reviews in Oral Biology and Medicine, The International Journal of Oral & Maxillofacial Surgery and The Journal of the American Dental Association, Oral Diseases, Head and Neck Surgery, Archives of Otolaryngology, Oral Oncology, The Laryngoscope, The Journal of Surgical Oncology, Head and Neck Pathology and The Journal of Oral and Maxillofacial Surgery. He served as the Oral Pathology editor of "Triple O" for six years, where he remains as an ad hoc reviewer and was an Associate Editor of The Journal of Oral Pathology and Medicine for 13 years.

He has authored or co-authored seven textbooks, including seven editions of the Textbook of Oral Pathology (Elsevier) and over 300 peer reviewed papers, abstracts and chapters, and has lectured extensively throughout the US, Central and South America, Europe and Asia.

Dr. Sciubba is presently President of Support for People with Oral and Head and Neck Cancer (SPOHNC) and was instrumental in the founding of this organization in 1991, as well as a co-founder of The Sjogren's Syndrome Foundation in 1983.


COURSE TITLEFormatsCREDITSAction
Bisphosphonate and Other Medication-Related Jaw Necrosis Part 1: Background, Incidence and Risk Factors (6th Edition)

Part 1 &ndash\; Background, Incidence and Risk Factors 6th Edition

Bisphosphonates and other medications are used increasingly more often by physicians in the treatment of benign and malignant bone diseases.&nbsp\; A number of reports describing a unique type of osteonecrosis in the maxillas and mandibles of patients on bisphosphonate therapy have been published over the past few years.&nbsp\; The sixth edition of this Guide discusses the pathogenesis of bisphosphonate and other medication-related osteonecrosis of the jaw (MRONJ) and outlines the risk factors that may affect onset of the condition in a population presenting for dental care.&nbsp\; A companion Guide, &ldquo\;Bisphosphonate and Other Medication-Related Jaw Necrosis Part 2 &ndash\; Clinical Management&rdquo\; will outline the strategies dentists should employ for patients with MRONJ.&nbsp\; It is suggested that Part 1 be thoroughly reviewed by the clinician before reading Part 2.

TextPDF1.5
Bisphosphonate Medication-Related Jaw Necrosis: Part 2: Clinical Management (6th Edition)

Part 2: Clinical Management (6th Edition)

A companion Guide, &ldquo\;Bisphosphonate and Other Medicated-Related Jaw Necrosis Part 1 &ndash\; Background, Incidence and Risk Factors&rdquo\; discussed the pathogenesis of bisphosphonate and other medication-related osteonecrosis of the jaws (MRONJ) and the risk factors responsible for initiating the condition. It is suggested that Part 1 be thoroughly reviewed by the clinician before reading Part 2. This sixth edition Guide discusses the clinical presentation of MRONJ, presents a stage-specific management system for patients with MRONJ, and through a four-year longitudinal case report, presents the clinical intraoral sequela of MRONJ.

TextPDF1.5
Performance of an Oral and Head and Neck Examination (7th Edition)

A comprehensive examination of the oral cavity, as well as the head and neck region, is an essential part of the evaluation of every new patient. The results become an integral part of the patient record and the basis for longitudinal comparisons. This Guide describes a logical sequence of evaluation that, if followed, will help prevent overlooking the evaluation of important anatomical structures. Included is a description of how structures should be examined and discussions of which structures should be inspected and which should be palpated. Questions sometimes arise regarding the completeness of an examination, especially when there is no record of negative findings. Included with this Guide is a form designed for use with individual patients that reflects the nine (9) step examination and provides an easy way to document what was done and when. It can serve as a necessary supplement to the recording of positive finds in the patient record. Incorporation of the Guide into the office policy manual will provide a ready answer to what is meant by the notation &ldquo\;Examination&rdquo\; in the progress notes.

TextPDF1.0

© 2024 MetLife Services and Solutions, LLC
Privacy/HIPAA Notices   EDI Availability

To learn more about the MetLife family of companies providing Dental HMO/Managed Care plans and the states where they provide benefits, please Click Here.